Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, the Company produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds and digital agriculture to assist farmers in decision-making. The Seeds and Genomics segment offers products, such as Germplasm and Biotechnology traits. Through its Agricultural Productivity segment, the Company manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.
Industry, Sector and Symbol:
- Sector: Basic Materials
- Industry: Agricultural Chemicals
- Sub-Industry: Fertilizers & Agricultural Chemicals
- Symbol: NYSE:MON
- CUSIP: 61166W10
- Web: www.monsanto.com
Capitalization:- Market Cap: $52.33216 billion
- Outstanding Shares: 439,323,000
Average Prices:- 50 Day Moving Avg: $117.37
- 200 Day Moving Avg: $116.53
- 52 Week Range: $97.35 - $119.60
P/E:- Trailing P/E Ratio: 25.79
- Foreward P/E Ratio: 22.03
- P/E Growth: 3.04
Sales & Book Value:- Annual Revenue: $14.52 billion
- Price / Sales: 3.61
- Book Value: $14.87 per share
- Price / Book: 8.03
Dividend:- Annual Dividend: $2.16
- Dividend Yield: 1.8%
Profitability:- EBIDTA: $4.19 billion
- Net Margins: 14.11%
- Return on Equity: 45.26%
- Return on Assets: 11.37%
Debt:- Debt-to-Equity Ratio: 1.11%
- Current Ratio: 1.44%
- Quick Ratio: 0.98%
Misc:- Average Volume: 1.59 million shs.
- Beta: 1.07
- Short Ratio: 1.66
Frequently Asked Questions for Monsanto Company (NYSE:MON)
What is Monsanto Company's stock symbol?
Monsanto Company trades on the New York Stock Exchange (NYSE) under the ticker symbol "MON."
How often does Monsanto Company pay dividends? What is the dividend yield for Monsanto Company?
Monsanto Company announced a quarterly dividend on Thursday, August 10th. Stockholders of record on Friday, October 6th will be paid a dividend of $0.54 per share on Friday, October 27th. This represents a $2.16 annualized dividend and a dividend yield of 1.81%. The ex-dividend date of this dividend is Thursday, October 5th. View Monsanto Company's Dividend History.
How were Monsanto Company's earnings last quarter?
Monsanto Company (NYSE:MON) released its quarterly earnings data on Wednesday, June, 28th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. The company earned $4.23 billion during the quarter, compared to the consensus estimate of $4.18 billion. Monsanto Company had a net margin of 14.11% and a return on equity of 45.26%. The company's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.17 EPS. View Monsanto Company's Earnings History.
When will Monsanto Company make its next earnings announcement?
Where is Monsanto Company's stock going? Where will Monsanto Company's stock price be in 2017?
14 analysts have issued 1 year target prices for Monsanto Company's shares. Their forecasts range from $104.00 to $128.00. On average, they expect Monsanto Company's share price to reach $123.25 in the next year. View Analyst Ratings for Monsanto Company.
Who are some of Monsanto Company's key competitors?
Some companies that are related to Monsanto Company include Syngenta AG (SYT), Potash Co. of Saskatchewan (POT), Agrium (AGU), Potash Corporation of Saskatchewan (POT), Sociedad Quimica y Minera S.A. (SQM), Agrium (AGU), Israel Chemicals Shs (ICL), Scotts Miracle-Gro Company (The) (SMG), Compass Minerals International (CMP), Sirius Minerals PLC (SXX), American Vanguard Corporation (AVD), Intrepid Potash (IPI), Ciner Resources LP (CINR), Marrone Bio Innovations (MBII), Incitec Pivot Ltd (IPL) and Nufarm Limited (NUF).
Who are Monsanto Company's key executives?
Monsanto Company's management team includes the folowing people:
- Hugh Grant, Chairman of the Board, Chief Executive Officer
- Brett D. Begemann, President, Chief Operating Officer
- Pierre C. Courduroux, Chief Financial Officer, Senior Vice President
- Steven C. Mizell, Chief Human Resource Officer, Executive Vice President
- Robert T. Fraley Ph.D., Executive Vice President, Chief Technology Officer
- David F. Snively J.D., Executive Vice President, General Counsel, Secretary
- Kerry J. Preete, Executive Vice President and Chief Strategy Officer
- Michael J. Frank, Senior Vice President, Chief Commercial Officer
- Janet M. Holloway, Senior Vice President, Chief of Staff and Community Relations
- Nicole M. Ringenberg, Vice President, Controller
Who owns Monsanto Company stock?
Monsanto Company's stock is owned by a number of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (6.99%), BlackRock Inc. (6.35%), State Street Corp (4.62%), FMR LLC (2.46%), Capital International Investors (1.93%) and Berkshire Hathaway Inc. (1.83%). Company insiders that own Monsanto Company stock include Brett D Begemann, Charles S Mcmillan, George Poste, Hugh Grant, Janet M Holloway, Kerry J Preete, Michael J Frank, Michael K Stern, Robert T Fraley, Steven Mizell and William U Parfet. View Institutional Ownership Trends for Monsanto Company.
Who sold Monsanto Company stock? Who is selling Monsanto Company stock?
Monsanto Company's stock was sold by a variety of institutional investors in the last quarter, including Davis Selected Advisers, FMR LLC, Capital Research Global Investors, Capital Guardian Trust Co., Capital International Investors, Wells Fargo & Company MN, Manning & Napier Advisors LLC and Renaissance Technologies LLC. Company insiders that have sold Monsanto Company stock in the last year include Brett D Begemann, Hugh Grant, Janet M Holloway, Kerry J Preete, Michael K Stern, Robert T Fraley and Steven Mizell. View Insider Buying and Selling for Monsanto Company.
Who bought Monsanto Company stock? Who is buying Monsanto Company stock?
Monsanto Company's stock was bought by a variety of institutional investors in the last quarter, including OZ Management LP, BlackRock Inc., Janus Henderson Group PLC, PSquared Asset Management AG, Vanguard Group Inc., Sand Grove Capital Management LLP, UBS Asset Management Americas Inc. and Neuberger Berman Group LLC. View Insider Buying and Selling for Monsanto Company.
How do I buy Monsanto Company stock?
Shares of Monsanto Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Monsanto Company's stock price today?
One share of Monsanto Company stock can currently be purchased for approximately $119.41.
MarketBeat Community Rating for Monsanto Company (NYSE MON)MarketBeat's community ratings are surveys of what our community members think about Monsanto Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Monsanto Company (NYSE:MON) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 7 Hold Ratings, 7 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.50) |
| Consensus Price Target: | $123.25 (3.22% upside) |
Analysts' Ratings History for Monsanto Company (NYSE:MON)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/15/2017 | Jefferies Group LLC | Reiterated Rating | Hold | $128.00 | Medium |  |
| 9/1/2017 | BMO Capital Markets | Reiterated Rating | Buy | $128.00 | Low | |
| 8/11/2017 | Piper Jaffray Companies | Set Price Target | Buy | $128.00 | Low | |
| 8/2/2017 | Royal Bank Of Canada | Reiterated Rating | Hold | $128.00 | Low | |
| 7/10/2017 | Citigroup Inc. | Reiterated Rating | Neutral | $125.00 -> $126.00 | Low | |
| 6/29/2017 | Barclays PLC | Boost Price Target | Equal Weight | $115.00 -> $120.00 | Low | |
| 6/27/2017 | Susquehanna Bancshares Inc | Reiterated Rating | Positive -> Neutral | $125.00 -> $128.00 | Low | |
| 1/6/2017 | CLSA | Upgrade | Underperform -> Outperform | | N/A | |
| 1/5/2017 | Sanford C. Bernstein | Set Price Target | Neutral | $105.00 | N/A | |
| 11/18/2016 | OTR Global | Upgrade | Negative -> Mixed | | N/A | |
| 10/9/2016 | Argus | Reiterated Rating | Buy | $128.00 | N/A | |
| 10/6/2016 | J P Morgan Chase & Co | Set Price Target | Buy | $128.00 | N/A | |
| 10/6/2016 | Deutsche Bank AG | Reiterated Rating | Buy | | N/A | |
| 10/3/2016 | Monness Crespi & Hardt | Lower Price Target | Buy | $130.00 -> $128.00 | N/A | |
| 9/27/2016 | Goldman Sachs Group, Inc. (The) | Upgrade | Sell -> Neutral | $104.00 | N/A | |
| 9/15/2016 | S&P Equity Research | Reiterated Rating | Positive | | N/A | |
| 5/27/2016 | Atlantic Securities | Downgrade | Overweight -> Neutral | $109.62 -> $105.00 | N/A | |
| 5/25/2016 | Macquarie | Set Price Target | Buy | $110.00 | N/A | |
| 5/24/2016 | Wells Fargo & Company | Reiterated Rating | Hold | | N/A | |
| 5/23/2016 | Vertical Research | Upgrade | Hold -> Buy | | N/A | |
| 5/13/2016 | Berenberg Bank | Set Price Target | Buy | $110.00 | N/A | |
| 4/9/2016 | Morgan Stanley | Reiterated Rating | Buy | | N/A | |
| 4/7/2016 | Bank of America Corporation | Reiterated Rating | Sell | $88.00 | N/A | |
| 3/3/2016 | Vertical Group | Downgrade | Buy -> Hold | | N/A | |
| 3/2/2016 | Credit Suisse Group | Lower Price Target | Outperform | $109.00 -> $97.00 | N/A | |
| 10/9/2015 | Stifel Nicolaus | Lower Price Target | Buy | $135.00 -> $115.00 | N/A | |
(Data available from 9/20/2015 forward)
Earnings History for Monsanto Company (NYSE:MON)Earnings History by Quarter for Monsanto Company (NYSE MON)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/4/2017 | | ($0.41) | | | | | N/A | |
| 6/28/2017 | Q3 17 | $1.74 | $1.93 | $4.18 billion | $4.23 billion | View | N/A | |
| 4/5/2017 | Q2 2017 | $2.79 | $3.19 | $4.73 billion | $5.07 billion | View | Listen | |
| 1/5/2017 | Q117 | $0.01 | $0.21 | | $2.22 billion | View | Listen | |
| 10/5/2016 | Q416 | ($0.02) | $0.07 | $2.38 billion | $2.56 billion | View | Listen | |
| 6/29/2016 | Q316 | $2.40 | $2.17 | $4.49 billion | $4.19 billion | View | Listen | |
| 4/6/2016 | Q216 | $2.44 | $2.42 | $4.81 billion | $4.53 billion | View | N/A | |
| 1/6/2016 | Q116 | ($0.22) | ($0.11) | $2.41 billion | $2.22 billion | View | Listen | |
| 10/7/2015 | Q415 | ($0.02) | ($0.19) | $2.79 billion | $2.36 billion | View | Listen | |
| 6/24/2015 | Q315 | $2.06 | $2.39 | $4.65 billion | $4.58 billion | View | Listen | |
| 4/1/2015 | Q215 | $2.93 | $2.90 | $5.58 billion | $5.20 billion | View | Listen | |
| 1/7/2015 | Q115 | $0.35 | $0.47 | $2.80 billion | $2.87 billion | View | Listen | |
| 10/8/2014 | Q414 | ($0.24) | ($0.27) | $2.41 billion | $2.63 billion | View | Listen | |
| 6/25/2014 | Q314 | $1.55 | $1.62 | $4.41 billion | $4.25 billion | View | Listen | |
| 4/2/2014 | Q214 | $3.08 | $3.15 | $5.81 billion | $5.83 billion | View | Listen | |
| 1/8/2014 | Q1 | $0.64 | $0.67 | $3.08 billion | $3.15 billion | View | Listen | |
| 10/2/2013 | Q413 | ($0.43) | ($0.47) | $2.24 billion | $2.20 billion | View | Listen | |
| 6/26/2013 | Q3 2013 | $1.59 | $1.66 | $4.41 billion | $4.25 billion | View | Listen | |
| 4/3/2013 | Q2 2013 | $2.58 | $2.73 | $5.29 billion | $5.47 billion | View | N/A | |
| 1/8/2013 | Q1 2013 | $0.37 | $0.62 | $2.64 billion | $2.93 billion | View | Listen | |
| 10/3/2012 | Q412 | ($0.43) | ($0.44) | $2.25 billion | $2.11 billion | View | N/A | |
| 6/27/2012 | | $1.58 | $1.63 | | | View | N/A | |
| 4/4/2012 | | $2.11 | $2.28 | | | View | N/A | |
| 1/5/2012 | | $0.17 | $0.23 | | | View | N/A | |
| 10/5/2011 | | ($0.27) | ($0.22) | | | View | N/A | |
| 4/6/2011 | | $1.84 | $1.87 | | | View | N/A | |
| 1/6/2011 | | $0.01 | $0.02 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Monsanto Company (NYSE:MON)2017 EPS Consensus Estimate: $5.75
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.04 | $3.57 | $1.81 |
| Q2 2017 | 2 | $2.57 | $2.63 | $2.60 |
| Q3 2017 | 1 | $1.77 | $1.77 | $1.77 |
| Q4 2017 | 1 | ($0.43) | ($0.43) | ($0.43) |
(Data provided by Zacks Investment Research)
Current Dividend Information for Monsanto Company (NYSE:MON)| Next Dividend: | 10/27/2017 |
| Annual Dividend: | $2.16 |
| Dividend Yield: | 1.81% |
| Dividend Growth: | 11.60% (3 Year Average) |
| Payout Ratio: | 46.75% (Trailing 12 Months of Earnings)
43.55% (Based on This Year's Estimates)
39.85% (Based on Next Year's Estimates)
|
| Track Record: | 7 Years of Consecutive Dividend Growth |
Dividend History by Quarter for Monsanto Company (NYSE MON)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 8/10/2017 | quarterly | $0.54 | 1.85% | 10/5/2017 | 10/6/2017 | 10/27/2017 |
| 6/6/2017 | quarterly | $0.54 | 1.83% | 7/5/2017 | 7/7/2017 | 7/28/2017 |
| 1/27/2017 | quarterly | $0.54 | 1.99% | 4/5/2017 | 4/7/2017 | 4/28/2017 |
| 12/6/2016 | quarterly | $0.54 | 2.04% | 1/4/2017 | 1/6/2017 | 1/27/2017 |
| 8/12/2016 | quarterly | $0.54 | 2.06% | 10/5/2016 | 10/7/2016 | 10/28/2016 |
| 6/9/2016 | quarterly | $0.54 | 1.98% | 7/6/2016 | 7/8/2016 | 7/29/2016 |
| 1/29/2016 | quarterly | $0.54 | 2.4% | 4/6/2016 | 4/8/2016 | 4/29/2016 |
| 12/7/2015 | quarterly | $0.54 | 2.23% | 1/6/2016 | 1/8/2016 | 1/29/2016 |
| 8/4/2015 | quarterly | $0.54 | 2.1% | 10/7/2015 | 10/9/2015 | 10/30/2015 |
| 6/8/2015 | quarterly | $0.49 | 1.72% | 6/30/2015 | 7/2/2015 | 7/24/2015 |
| 2/2/2015 | quarterly | $0.49 | 1.65% | 3/31/2015 | 4/2/2015 | 4/24/2015 |
| 12/8/2014 | quarterly | $0.49 | 1.63% | 1/7/2015 | 1/9/2015 | 1/30/2015 |
| 8/5/2014 | quarterly | $0.49 | 1.69% | 10/8/2014 | 10/10/2014 | 10/31/2014 |
| 6/6/2014 | quarterly | $0.43 | 1.42% | 7/1/2014 | 7/3/2014 | 7/25/2014 |
| 1/28/2014 | quarterly | $0.43 | 1.61% | 4/2/2014 | 4/4/2014 | 4/25/2014 |
| 12/9/2013 | quarterly | $0.43 | 1.54% | 1/8/2014 | 1/10/2014 | 1/31/2014 |
| 8/6/2013 | quarterly | $0.43 | 1.81% | 10/2/2013 | 10/4/2013 | 10/25/2013 |
| 6/6/2013 | quarterly | $0.38 | 1.48% | 7/2/2013 | 7/5/2013 | 7/26/2013 |
| 1/31/2013 | quarterly | $0.38 | 1.47% | 4/3/2013 | 4/5/2013 | 4/26/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Monsanto Company (NYSE:MON)Insider Ownership Percentage: 0.79%
Institutional Ownership Percentage: 74.78%
Insider Trades by Quarter for Monsanto Company (NYSE:MON)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 7/10/2017 | Robert T. Fraley | EVP | Sell | 52,410 | $117.95 | $6,181,759.50 | |
| 7/3/2017 | Steven Mizell | EVP | Sell | 11,300 | $118.57 | $1,339,841.00 | |
| 6/13/2017 | Janet M Holloway | SVP | Sell | 7,423 | $118.00 | $875,914.00 | |
| 6/2/2017 | Janet M Holloway | SVP | Sell | 3,337 | $118.00 | $393,766.00 | |
| 5/3/2017 | Kerry J Preete | EVP | Sell | 11,346 | $116.86 | $1,325,893.56 | |
| 4/17/2017 | Brett D Begemann | COO | Sell | 80,940 | $116.13 | $9,399,562.20 | |
| 4/10/2017 | Hugh Grant | CEO | Sell | 149,230 | $116.15 | $17,333,064.50 | |
| 4/10/2017 | Steven Mizell | EVP | Sell | 13,700 | $116.11 | $1,590,707.00 | |
| 1/25/2017 | Michael K Stern | CEO | Sell | 5,670 | $110.00 | $623,700.00 | |
| 1/10/2017 | Steven Mizell | EVP | Sell | 2,525 | $108.56 | $274,114.00 | |
| 11/17/2016 | Kerry J. Preete | EVP | Sell | 2,745 | $100.96 | $277,135.20 | |
| 10/14/2016 | Robert T Fraley | EVP | Sell | 80,631 | $102.04 | $8,227,587.24 | |
| 10/10/2016 | Charles S Mcmillan | Director | Buy | 3,500 | $103.23 | $361,305.00 | |
| 10/10/2016 | Steven Mizell | EVP | Sell | 310 | $103.09 | $31,957.90 | |
| 7/14/2016 | Brett D Begemann | COO | Sell | 27,980 | $103.62 | $2,899,287.60 | |
| 7/13/2016 | Michael K Stern | CEO | Sell | 12,797 | $101.77 | $1,302,350.69 | |
| 4/19/2016 | George Poste | Director | Sell | 1,136 | $91.93 | $104,432.48 | |
| 4/14/2016 | Steven Mizell | EVP | Sell | 9,500 | $89.06 | $846,070.00 | |
| 4/12/2016 | Charles S Mcmillan | Director | Buy | 3,500 | $87.25 | $305,375.00 | |
| 4/12/2016 | Michael J Frank | VP | Sell | 2,000 | $87.49 | $174,980.00 | |
| 4/11/2016 | Steven Mizell | EVP | Sell | 3,900 | $86.87 | $338,793.00 | |
| 11/17/2015 | Kerry J. Preete | EVP | Sell | 4,667 | $95.62 | $446,258.54 | |
| 10/21/2015 | William U Parfet | Director | Sell | 17,000 | $91.16 | $1,549,720.00 | |
| 10/13/2015 | Steven Mizell | VP | Sell | 6,100 | $89.40 | $545,340.00 | |
| 4/15/2015 | Kerry J Preete | EVP | Sell | 27,580 | $119.37 | $3,292,224.60 | |
| 4/8/2015 | Tom D Hartley | VP | Sell | 4,600 | $117.91 | $542,386.00 | |
| 2/13/2015 | Michael K Stern | COO | Sell | 1,391 | $125.00 | $173,875.00 | |
| 1/20/2015 | David F Snively | EVP | Sell | 29,521 | $117.14 | $3,458,089.94 | |
| 1/12/2015 | Steven Mizell | VP | Sell | 20,500 | $118.72 | $2,433,760.00 | |
| 11/17/2014 | Nicole M Ringenberg | VP | Sell | 12,780 | $118.83 | $1,518,647.40 | |
| 10/15/2014 | Robert T Fraley | EVP | Sell | 10,679 | $107.93 | $1,152,584.47 | |
| 10/14/2014 | Nicole M Ringenberg | VP | Sell | 2,500 | $108.01 | $270,025.00 | |
| 10/13/2014 | Steven Mizell | VP | Sell | 3,480 | $106.08 | $369,158.40 | |
| 9/3/2014 | Kerry J Preete | EVP | Sell | 3,827 | $115.50 | $442,018.50 | |
| 7/8/2014 | Michael J Frank | VP | Sell | 7,500 | $124.53 | $933,975.00 | |
| 7/7/2014 | Robert T Fraley | EVP | Sell | 54,740 | $125.32 | $6,860,016.80 | |
| 7/3/2014 | David F Snively | EVP | Sell | 35,220 | $126.25 | $4,446,525.00 | |
| 7/3/2014 | William U Parfet | Director | Sell | 23,800 | $126.52 | $3,011,176.00 | |
| 5/23/2014 | Janet M Holloway | SVP | Sell | 21,280 | $120.00 | $2,553,600.00 | |
| 5/7/2014 | Kerry Preete | EVP | Sell | 49,850 | $115.00 | $5,732,750.00 | |
| 4/15/2014 | Hugh Grant | CEO | Sell | 95,000 | $110.33 | $10,481,350.00 | |
| 4/15/2014 | Tom Hartley | VP | Sell | 7,900 | $110.51 | $873,029.00 | |
| 1/17/2014 | Hugh Grant | CEO | Sell | 44,179 | $112.69 | $4,978,531.51 | |
| 1/16/2014 | Robert Fraley | EVP | Sell | 64,850 | $112.57 | $7,300,164.50 | |
| 1/14/2014 | Steven Mizell | VP | Sell | 24,000 | $112.05 | $2,689,200.00 | |
| 11/11/2013 | Nicole Ringenberg | VP | Sell | 13,560 | $107.04 | $1,451,462.40 | |
| 10/15/2013 | Tom Hartley | VP | Sell | 5,860 | $105.70 | $619,402.00 | |
| 10/8/2013 | Steven Mizell | VP | Sell | 11,370 | $104.50 | $1,188,165.00 | |
| 10/7/2013 | Nicole Ringenberg | VP | Sell | 3,500 | $105.02 | $367,570.00 | |
| 9/4/2013 | Kerry Preete | EVP | Sell | 5,276 | $99.00 | $522,324.00 | |
| 7/19/2013 | Gerald A Steiner | EVP | Sell | 12,293 | $104.00 | $1,278,472.00 | |
| 7/9/2013 | Tom D Hartley | VP | Sell | 6,000 | $100.15 | $600,900.00 | |
| 7/8/2013 | Janet M Holloway | SVP | Sell | 10,700 | $98.80 | $1,057,160.00 | |
| 7/3/2013 | Hugh Grant | CEO | Sell | 40,000 | $97.74 | $3,909,600.00 | |
| 7/2/2013 | Steven Mizell | VP | Sell | 37,000 | $97.71 | $3,615,270.00 | |
| 5/13/2013 | David F Snively | EVP | Sell | 106,366 | $107.24 | $11,406,689.84 | |
| 5/1/2013 | Pierre Courduroux | CFO | Sell | 5,720 | $105.47 | $603,288.40 | |
(Data available from 1/1/2013 forward)
Headline Trends for Monsanto Company (NYSE:MON)
Latest Headlines for Monsanto Company (NYSE:MON)
| Source: |
|
Monsanto Company (MON) Chart for Wednesday, September, 20, 2017
